175 related articles for article (PubMed ID: 27031095)
41. HPV16E7-Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3
Kuo P; Tuong ZK; Teoh SM; Frazer IH; Mattarollo SR; Leggatt GR
J Invest Dermatol; 2018 Jun; 138(6):1348-1359. PubMed ID: 29277541
[TBL] [Abstract][Full Text] [Related]
42. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
[TBL] [Abstract][Full Text] [Related]
43. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
44. Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice.
Santos JMO; Fernandes M; Araújo R; Sousa H; Ribeiro J; Bastos MMSM; Oliveira PA; Carmo D; Casaca F; Silva S; Teixeira AL; Gil da Costa RM; Medeiros R
Life Sci; 2017 Apr; 175():31-36. PubMed ID: 28302562
[TBL] [Abstract][Full Text] [Related]
45. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
46. Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response.
Zhang J; Burn C; Young K; Wilson M; Ly K; Budhwani M; Tschirley A; Braithwaite A; Baird M; Hibma M
Sci Rep; 2018 Feb; 8(1):2373. PubMed ID: 29402982
[TBL] [Abstract][Full Text] [Related]
47. Interaction between the human papillomavirus 16 E7 oncoprotein and gelsolin ignites cancer cell motility and invasiveness.
Matarrese P; Abbruzzese C; Mileo AM; Vona R; Ascione B; Visca P; Rollo F; Benevolo M; Malorni W; Paggi MG
Oncotarget; 2016 Aug; 7(32):50972-50985. PubMed ID: 27072581
[TBL] [Abstract][Full Text] [Related]
48. The human papillomavirus E7 oncoprotein as a regulator of transcription.
Songock WK; Kim SM; Bodily JM
Virus Res; 2017 Mar; 231():56-75. PubMed ID: 27818212
[TBL] [Abstract][Full Text] [Related]
49. Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70.
Zhou L; Zhu T; Ye X; Yang L; Wang B; Liang X; Lu L; Tsao YP; Chen SL; Li J; Xiao X
Hum Gene Ther; 2010 Jan; 21(1):109-19. PubMed ID: 19715402
[TBL] [Abstract][Full Text] [Related]
50. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
Banerjee NS; Genovese NJ; Noya F; Chien WM; Broker TR; Chow LT
J Virol; 2006 Jul; 80(13):6517-24. PubMed ID: 16775338
[TBL] [Abstract][Full Text] [Related]
51. [Protective immune responses induced by a recombinant Listeria monocytogenes delivering HPV16 E7].
Jia Y; Yin Y; Tan W; Fu H; Chen X; Pan Z; Jiao X
Wei Sheng Wu Xue Bao; 2012 Dec; 52(12):1508-14. PubMed ID: 23457800
[TBL] [Abstract][Full Text] [Related]
52. HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.
Luo X; Donnelly CR; Gong W; Heath BR; Hao Y; Donnelly LA; Moghbeli T; Tan YS; Lin X; Bellile E; Kansy BA; Carey TE; Brenner JC; Cheng L; Polverini PJ; Morgan MA; Wen H; Prince ME; Ferris RL; Xie Y; Young S; Wolf GT; Chen Q; Lei YL
J Clin Invest; 2020 Apr; 130(4):1635-1652. PubMed ID: 31874109
[TBL] [Abstract][Full Text] [Related]
53. Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53.
Guo C; Liu K; Zheng Y; Luo H; Chen H; Huang L
Apoptosis; 2011 Jun; 16(6):606-18. PubMed ID: 21475994
[TBL] [Abstract][Full Text] [Related]
54. Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes.
Frazer IH; Fernando GJ; Fowler N; Leggatt GR; Lambert PF; Liem A; Malcolm K; Tindle RW
Eur J Immunol; 1998 Sep; 28(9):2791-800. PubMed ID: 9754566
[TBL] [Abstract][Full Text] [Related]
55. Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.
Nieto K; Kern A; Leuchs B; Gissmann L; Müller M; Kleinschmidt JA
Antivir Ther; 2009; 14(8):1125-37. PubMed ID: 20032542
[TBL] [Abstract][Full Text] [Related]
56. The Subcellular Localisation of the Human Papillomavirus (HPV) 16 E7 Protein in Cervical Cancer Cells and Its Perturbation by RNA Aptamers.
Cesur Ö; Nicol C; Groves H; Mankouri J; Blair GE; Stonehouse NJ
Viruses; 2015 Jun; 7(7):3443-61. PubMed ID: 26131956
[TBL] [Abstract][Full Text] [Related]
57. In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16.
Accardi L; Paolini F; Mandarino A; Percario Z; Di Bonito P; Di Carlo V; Affabris E; Giorgi C; Amici C; Venuti A
Int J Cancer; 2014 Jun; 134(11):2742-7. PubMed ID: 24226851
[TBL] [Abstract][Full Text] [Related]
58. The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.
Hasan UA; Zannetti C; Parroche P; Goutagny N; Malfroy M; Roblot G; Carreira C; Hussain I; Müller M; Taylor-Papadimitriou J; Picard D; Sylla BS; Trinchieri G; Medzhitov R; Tommasino M
J Exp Med; 2013 Jul; 210(7):1369-87. PubMed ID: 23752229
[TBL] [Abstract][Full Text] [Related]
59. Increased Response of Human T-Lymphocytes by Dendritic Cells Pulsed with HPV16E7 and Pleurotus sajor-caju-β-glucan (PBG).
Roopngam PE
Iran J Immunol; 2018 Dec; 15(4):246-255. PubMed ID: 30593739
[TBL] [Abstract][Full Text] [Related]
60. The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.
Ferrantelli F; Arenaccio C; Manfredi F; Olivetta E; Chiozzini C; Leone P; Percario Z; Ascione A; Flego M; Di Bonito P; Accardi L; Federico M
Int J Nanomedicine; 2019; 14():8755-8768. PubMed ID: 31806970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
